Related Experiment Video
Updated: Feb 24, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
Natural History of Localized and Locally Advanced Atypical Lung Carcinoids after Complete Resection: A Joined
Recurrence-free survival after atypical lung carcinoid resection is influenced by lymph node involvement. Stratifying follow-up intervals based on nodal status is recommended due to suboptimal current imaging practices.
Area of Science:
- Thoracic Surgery
- Oncology
- Pulmonary Medicine
Background:
- Atypical lung carcinoids (AC) have an ill-defined natural history and optimal follow-up strategies.
- Complete resection (R0) is the primary treatment for stage I-III pulmonary AC.
Purpose of the Study:
- To analyze recurrence-free survival (RFS) after complete resection of pulmonary AC.
- To identify prognostic parameters, recurrence locations, and optimal follow-up modalities.
Main Methods:
- Retrospective review of 62 patients with AC treated between 1998-2008.
- Central pathological review and exclusion of specific patient subgroups.
- Analysis of recurrence-free survival and associated prognostic factors.
Main Results:
- 35% of patients experienced recurrence within a median follow-up of 91 months.
- Lymph node involvement, stage, mitotic count, and surgery type were associated with RFS.
- Lymph node involvement was a significant independent predictor of RFS in multivariate analysis.
Conclusions:
- Recurrences after AC resection occur mainly within the first 5 years.
- Lymph node involvement can guide follow-up stratification for R0 patients.
- Current imaging follow-up practices for AC are suboptimal.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025